Restricted accessArticle commentaryFirst published online 2019-8
Commentary: Double-Layer Carotid Stents: From the Clinical Need,through a Stent-in-Stent Strategy,to Effective Plaque Isolation… the Journey Toward Safe Carotid Revascularization Using the Endovascular Route
SchnaudigelSGröschelKPilgramSMet al. New brain lesions after carotid stenting versus carotid endarterectomy: a systematic review of the literature. Stroke. 2008;39:1911-1919.
3.
BrottTGHobsonRW2ndHowardGet al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010;363:11-23.
4.
ConradMFBoulomVMukhopadhyaySet al. Progression of asymptomatic carotid stenosis despite optimal medical therapy. J Vasc Surg. 2013;58:128-135.
5.
ConradMFMichalczykMJOpalaczAet al. The natural history of asymptomatic severe carotid artery stenosis. J Vasc Surg. 2014;60:1218-1226.
6.
KakkosSKNicolaidesANCharalambousIet al. Predictors and clinical significance of progression or regression of asymptomatic carotid stenosis. J Vasc Surg. 2014;59:956-967.
7.
GoyalMMenonBKvan ZwamWHet al. Endovascular thrombectomy after large-vessel ischaemic stroke: A meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387:1723-1731.
8.
SpagnoliLGMaurielloASangiorgiGet al. Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAMA. 2004;292:1845-1852.
9.
VirmaniRLadichERBurkeAPet al. Histopathology of carotid atherosclerotic disease. Neurosurgery. 2006;59(Suppl 3):S219-227.
10.
MaurielloAServadeiFSangiorgiGet al. Asymptomatic carotid plaque rupture with unexpected thrombosis over a non-canonical vulnerable lesion. Atherosclerosis. 2011;218:356-362.
11.
LalBKMeschiaJFBrottTG.Clinical need, design, and goals for the Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis trial. Semin Vasc Surg. 2017;30(1):2-7.
12.
PaulSLSturmJWDeweyHMet al. Long-term outcome in the North East Melbourne Stroke Incidence study: Predictors of quality of life at 5 years after stroke. Stroke. 2005;36:2082-2086.
13.
MusialekPHopf-JensenS.Commentary: Carotid artery revascularization for stroke prevention: A new era. J Endovasc Ther. 2017;24:138-148.
14.
MusialekPGrunwaldIQ.How asymptomatic is “asymptomatic” carotid stenosis? Resolving fundamental confusion(s) – and confusions yet to be resolved. Pol Arch Intern Med. 2017;127:718-719.
15.
TrystulaMTomaszewskiTPachalskaM.Health-related quality of life in ischaemic stroke survivors after carotid endarterectomy (CEA) and carotid artery stenting (CAS): Confounder-controlled analysis. Adv Interv Cardiol. Published online April 13, 2019. DOI:10.5114/aic.2019.84441
16.
MusialekP.Update on results with the CGuard MicroNET covered stent for CAS: Does it cause in-stent restenosis or other long-term problems? Can it have value in other vascular beds?Presented at: Vascular Endovascular Issues Techniques Horizons (VEITH); November 22, 2018; New York, NY, USA. https://www.veithsymposium.org/abstracts/2018/vei/823.pdf .
17.
BiasiGMFroioADiethrichEBet al. Carotid plaque echolucency increases the risk of stroke in carotid stenting: The Imaging in Carotid Angioplasty and Risk of Stroke (ICAROS) study. Circulation. 2004;110:756-762.
18.
MontorsiPCaputiLGalliSet al. Microembolization during carotid artery stenting in patients with high-risk, lipid-rich plaque. A randomized trial of proximal versus distal cerebral protection. J Am Coll Cardiol. 2011;58:1656-1663.
19.
BijuklicKWandlerAHaziziFet al. The PROFI study (Prevention of Cerebral Embolization by Proximal Balloon Occlusion Compared to Filter Protection During Carotid Artery Stenting): A prospective randomized trial. J Am Coll Cardiol. 2012;59:1383-1389.
20.
LealIOrgazAFloresÁet al. A diffusion-weighted magnetic resonance imaging-based study of transcervical carotid stenting with flow reversal versus transfemoral filter protection. J Vasc Surg. 2012;56:1585-1590.
21.
BosiersMde DonatoGDelooseKet al. Does free cell area influence the outcome in carotid artery stenting?Eur J Vasc Endovasc Surg. 2007;33:135-141.
22.
StabileEde DonatoGMusialekPet al. Use of dual-layered stents in endovascular treatment of extracranial stenosis of the internal carotid artery: results of a patient-based meta-analysis of 4 clinical studies. JACC Cardiovasc Interv. 2018;11:2405-2411.
23.
PieniazekPMusialekPKablak-ZiembickaAet al. Carotid artery stenting with patient- and lesion-tailored selection of the neuroprotection system and stent type: Early and 5-year results from a prospective academic registry of 535 consecutive procedures (TARGET-CAS). J Endovasc Ther. 2008;15:249-262.
24.
ParaskevasKIVeithFJParodiJC.Transcervical carotid artery stenting (CAS) with flow reversal: a promising technique for the reduction of strokes associated with CAS. J Endovasc Ther. 2016;23:255-257.
25.
FairmanRGrayWAScicliAPet al. The CAPTURE registry: Analysis of strokes resulting from carotid artery stenting in the post approval setting: timing, location, severity, and type. Ann Surg. 2007;246:551-556.
26.
ParaskevasKIMikhailidisDPVeithFJ.Mechanisms to explain the poor results of carotid artery stenting (CAS) in symptomatic patients to date and options to improve CAS outcomes. J Vasc Surg. 2010;52:1367-1375.
27.
HaradaKOshikataSKajiharaM.Optical coherence tomography of tissue prolapse after carotid artery stenting using closed cell design stents for unstable plaque. J Neurointervent Surg. 2018;10:229-234.
28.
BrottTGHowardGRoubinGSet al. Long-term results of stenting versus endarterectomy for carotid-artery stenosis. N Engl J Med. 2016;374:1021-1031.
29.
MousaABroceM.Commentary: Carotid endarterectomy before and after CREST. J Endovasc Ther. 2016;23:536-537.
30.
CohenDJStolkerJMWangKet al. CREST Investigators. Health-related quality of life after carotid stenting versus carotid endarterectomy: results from CREST (Carotid Revascularization Endarterectomy Versus Stenting Trial). J Am Coll Cardiol. 2011;58:1557-1565.
31.
SardarPChatterjeeSAronowHDet al. Carotid artery stenting versus endarterectomy for stroke prevention: a meta-analysis of clinical trials. J Am Coll Cardiol. 2017;69:2266-2275.
32.
ReimersBNikasDStabileEet al. Preliminary experience with optical coherence tomography imaging to evaluate carotid artery stents: Safety, feasibility, and techniques. EuroIntervention. 2011;7:98-105.
33.
De DonatoGSetacciFSirignanoPet al. Optical coherence tomography after carotid stenting: Rate of stent malapposition, plaque prolapse and fibrous cap rupture according to stent design. Eur J Vasc Endovasc Surg. 2013;45:579-587.
34.
LiuRJiangYXiongYet al. An optical coherence tomography assessment of stent strut apposition based on the presence of lipid-rich plaque in the carotid artery. J Endovasc Ther. 2015;22:942-949.
35.
ShinozakiNOgataNIkariY.Plaque protrusion detected by intravascular ultrasound during carotid artery stenting. J Stroke Cerebrovasc Dis. 2014;23:2622-2625.
36.
YamadaKYoshimuraSMiuraMet al. Potential of new-generation double-layer micromesh stent for carotid artery stenting in patients with unstable plaque: a preliminary result using OFDI analysis. World Neurosurg. 2017;105:321-326.
37.
AikawaHKodamaTNiiKet al. Intraprocedural plaque protrusion resulting in cerebral embolism during carotid angioplasty with stenting. Radiat Med. 2008;26:318-323.
38.
KotsugiMTakayamaKMyouchinKet al. Carotid artery stenting: investigation of plaque protrusion incidence and prognosis. JACC Cardiovasc Interv. 2017;10:824-831.
39.
OkazakiTSakamotoSShinagawaKet al. Detection of in-stent protrusion (ISP) by intravascular ultrasound during carotid stenting: Usefulness of stent-in-stent placement for ISP. Eur Radiol. 2019;29:77-84.
40.
MusialekPHopkinsLNSiddiquiAH.One swallow does not a summer make but many swallows do: Accumulating clinical evidence for nearly-eliminated peri-procedural and 30-day complications with mesh-covered stents transforms the carotid revascularisation field. Adv Interv Cardiol. 2017;13:95-106.
TanakaKKitagawaTYamanaNet al. Mobility of an in-stent plaque protrusion detected with carotid duplex during the carotid artery stenting procedure. Med Ultrason. 2019;21:89-92.
43.
StankovicGColomboAPresbiteroPet al. Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: the Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) trial. Circulation. 2003;108:37-42.
44.
ChoudhuryRPBlackmanDJChannonKM.Distal embolisation in percutaneous saphenous vein graft intervention despite use of a polymer covered stent. Heart. 2005;91:1259.
45.
BlackmanDJChoudhuryRPBanningAPet al. Failure of the Symbiot PTFE-covered stent to reduce distal embolization during percutaneous coronary intervention in saphenous vein grafts. J Invasive Cardiol. 2005;17:609-612.
46.
AmmiMHenniSSalomonDuMontLet al. Lower rate of restenosis and reinterventions with covered vs bare metal stents following innominate artery stenting. J Endovasc Ther. 2019;26(3):385-390.
47.
de BorstGJ. Commentary: Innominate artery stenting: the continuing saga of “who, when, and how”?J Endovasc Ther. 2019;26(3):391-393.
48.
SchillingerMDickPWiestGet al. Covered versus bare self-expanding stents for endovascular treatment of carotid artery stenosis: A stopped randomized trial. J Endovasc Ther. 2006;13:312-319.
49.
SzólicsASztrihaLKSzikraPet al. The use of covered stents for the endovascular treatment of extracranial internal carotid artery stenosis: A prospective study with a 5-year follow-up. Eur Radiol. 2010;20:1772-1776.
50.
MyouchinKTakayamaKWadaTet al. Carotid artery stenting using a closed-cell stent-in-stent technique for unstable plaque. J Endovasc Ther. 2019;26(4):565–571.
51.
WissgottCSchmidtWBrandtCet al. Preliminary clinical results and mechanical behavior of a new double-layer carotid stent. J Endovasc Ther. 2015;22:634-639.
52.
MusialekPKolvenbachRSchoferJ. Regarding: “Acute occlusions of dual-layer carotid stents after endovascular emergency treatment of tandem lesions.”Stroke. 2017;48:e364.
53.
SchoferJMusiałekPBijuklicKet al. A Prospective, multicenter study of a novel mesh-covered carotid stent: the CGuard CARENET trial (Carotid Embolic Protection Using MicroNet). JACC Cardiovasc Interv. 2015;8:1229-1234.
54.
WissgottCSchmidtWBrandt-WunderlichCet al. Clinical results and mechanical properties of the Carotid CGUARD Double-Layered Embolic Prevention Stent. J Endovasc Ther. 2017;24:130-137.
55.
NerlaRCastriotaFMicariAet al. Carotid artery stenting with a new-generation double-mesh stent in three high-volume Italian centres: Clinical results of a multidisciplinary approach. EuroIntervention. 2016;12:e677-83.
56.
UmemotoTde DonatoGPacchioniAet al. Optical coherence tomography assessment of new generation mesh-covered stents after carotid stenting. EuroIntervention. 2017;13:1347-1354.
57.
MusialekPStabileE.Residual plaque prolapse with novel dual-layer carotid stents: Is it mesh-covered or not?EuroIntervention. 2017;13:1266-1268.
58.
MazurekAPartykaLTrystulaMet al. Highly-calcific carotid lesions endovascular management in symptomatic and increased-stroke-risk asymptomatic patients using the CGuard™ dual-layer carotid stent system: Analysis from the PARADIGM study. Catheter Cardiovasc Interv. Published online April 3, 2019. doi: 10.1002/ccd.28219.
59.
MusialekPMazurekATrystulaMet al. Novel PARADIGM in carotid revascularisation: Prospective evaluation of All-comer peRcutaneous cArotiD revascularisation in symptomatic and Increased-risk asymptomatic carotid artery stenosis using CGuard™ MicroNet-covered embolic prevention stent system. EuroIntervention. 2016;12:e658-670.
60.
CapocciaLSirignanoPMansourWet al. Peri-procedural brain lesions prevention in CAS (3PCAS): Randomized trial comparing CGuard™ stent vs. Wallstent™. Int J Cardiol. 2019;279:148-153.
61.
FröbertOLagerqvistBOlivecronaGKet al. Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med. 2013;369:1587-1597.
62.
MusialekP.TASTE-less endpoint of 30-day mortality (and some other issues with TASTE) in evaluating the effectiveness of thrombus aspiration in STEMI: Not the “evidence” to change the current practice of routine consideration of manual thrombus extraction. Polish Heart J. 2014;72:479-487.
63.
O’NeillZRDeptuckHMQuongLet al. Who says “no” to participating in stroke clinical trials and why: an observational study from the Vancouver Stroke Program. Trials. 2019;20:313.
64.
EcksteinHHReiffTRinglebPet al; SPACE 2 Investigators. SPACE-2: A missed opportunity to compare carotid endarterectomy, carotid stenting, and best medical treatment in patients with asymptomatic carotid stenoses. Eur J Vasc Endovasc Surg. 2016;51(6):761–765.
65.
AboyansVRiccoJBBartelinkMELet al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2018;55:305–368.
66.
DeMartinoRRBrookeBSNealDet al. Development of a validated model to predict 30-day stroke and 1-year survival after carotid endarterectomy for asymptomatic stenosis using the Vascular Quality Initiative. J Vasc Surg. 2017;66:433-444.
67.
MusialekPPieniazekPTraczWet al. Safety of embolic protection device-assisted and unprotected intravascular ultrasound in evaluating carotid artery atherosclerotic lesions. Med Sci Monit. 2012;18:MT7-18.
68.
SolomonNAGlickHARussoCJet al. Patient preferences for stroke outcomes. Stroke. 1994;25:1721-1725.
69.
ClevelandTJGainesPAVenablesGS.Carotid artery stenosis: Patients should have access to all treatments. BMJ. 2010;340:c1467.
70.
MalasMBDakour-AridiHKashyapVSet al. Outcomes of transcarotid revascularization with dynamic flow reversal versus carotid endarterectomy in the Transcarotid Revascularization Surveillance Project (Abstract). J Vasc Surg. 2019;69:e95-e96.
